d.bakker
TL2 · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 12 May 2025 · last posted 3d
78Posts here
3Topics
0Solutions
862Likes received
506Likes given
24Badges
189Days visited
2.6kPosts read
Recent activity
Full stream-
Revisiting: How this community labels and discusses unrefereed work Replied, post #34 · Evidence › Preprints · 25 Jul 2026 · 1 like How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Common supplements people ask about, assessed one at a time Replied, post #67 · Practice › Interactions · 19 Jul 2026 · 4 likes Answering the question post #63 raises rather than the one it answers. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #48 · Clinical › Prescriber conversations · 18 Jul 2026 · 16 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Old habit: I write down the…
-
What I would want from a home test that does not exist yet Replied, post #35 · Analytics › Home & field testing · 12 Jul 2026 · 4 likes Taking post #34 at face value and following it one step further. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic…
-
Seven-day rolling means and why weekly readings mislead Replied, post #8 · Outcomes › Progress reports · 10 Jul 2026 · 4 likes Nobody has said the unglamorous part of seven-day rolling yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #95 · Safety › Contraindications · 2 Jul 2026 · 4 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Deletion sequences: expected mass shifts by residue — the long version Started this topic · Analytics › Impurities & related substances · 1 Jul 2026 · 3 likes On the subject in the title: Deletion sequences: expected mass shifts by residue — the long version Working notes rather than a conclusion. Deletion sequences keeps…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #27 · Outcomes › Body composition · 23 Jun 2026 · 18 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month. That is all I can say without guessing.
-
Follow-up: Reconciling a label claim with a content assay Replied, post #26 · Analytics › COA interpretation · 18 Jun 2026 · 1 like The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #116 · Compounds › Tirzepatide · 2 Jun 2026 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Five questions in one post gets you one answer — how to split them Replied, post #82 · Start Here › How to Ask · 16 May 2026 · 4 likes I think the five questions question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #98 · Practice › Interactions · 4 May 2026 · 1 like I would call the community position on Metformin co-administration likely rather than established, and I would be comfortable defending that hedge.